Early versus late surgery for ileo-caecal Crohn's disease

被引:98
作者
Aratari, A.
Papi, C.
Leandro, G.
Viscido, A.
Capurso, L.
Caprilli, R.
机构
[1] Univ Roma La Sapienza, Dept Clin Sci, Gastroenterol Unit, I-00161 Rome, Italy
[2] S Filippo Neri Hosp, Gastroenterol Unit, Rome, Italy
[3] IRCCS, Gastroenterol Unit, Bari, Italy
关键词
D O I
10.1111/j.1365-2036.2007.03515.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Surgical resection is almost inevitable in Crohn's disease. Surgery is usually performed for refractory or complicated disease: no studies appear to have been carried out, so far, to evaluate the potential benefits of performing surgery early in the course of the disease. Aim To compare the long-term course of Crohn's disease following ileo-caecal resection performed at the time of diagnosis ( early surgery) or during the course of the disease ( late surgery). Patients and methods Overall 207 patients with ileo-caecal Crohn's disease at their first resection were reviewed: 83 patients underwent surgery at the time of diagnosis ( early surgery), while 124 underwent surgery 54.2 months ( range 1-438) after diagnosis ( late surgery). The mean follow-up after surgery was 147 months ( range 12-534). The primary endpoint was clinical recurrence, defined as need for corticosteroids for symptomatic disease in the presence of endoscopic and/or radiologic recurrence. Secondary endpoints were need for immunosuppressants and surgical recurrence. Statistical analysis: Kaplan-Meier survival method and Cox proportional hazards regression model. Results Within 10 years after surgery, the cumulative probability of clinical recurrence was significantly lower in the early surgery group ( Log Rank test P = 0.01). A trend was observed regarding the need for immunosuppressants ( P = 0.05). No difference was observed regarding surgical recurrence. At multivariate analysis, early surgery was the only independent variable associated with a reduced risk of clinical recurrence ( Hazard ratio, HR = 0.57; 95% CI 0.35 to 0.92, P = 0.02), but not with need for immunosuppressants and surgical recurrence ( HR = 0.51; 95% CI 0.20 to 1.30, P = 0.15; HR = 0.66; 95% CI 0.33 to 1.35, P = 0.25, respectively). Conclusion Early surgery prolongs clinical remission compared to surgery performed during the course of the disease, but the natural history of disease is not modified.
引用
收藏
页码:1303 / 1312
页数:10
相关论文
共 42 条
[1]
SURGICAL ASPECTS OF INFLAMMATORY BOWEL-DISEASE [J].
ALEXANDERWILLIAMS, J .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1990, 25 :39-42
[2]
STRATEGY FOR MANAGEMENT OF DISTAL ILEAL CROHNS-DISEASE [J].
ANDREWS, HA ;
KEIGHLEY, MRB ;
ALEXANDERWILLIAMS, J ;
ALLAN, RN .
BRITISH JOURNAL OF SURGERY, 1991, 78 (06) :679-682
[3]
Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease [J].
Bernell, O ;
Lapidus, A ;
Hellers, G .
BRITISH JOURNAL OF SURGERY, 2000, 87 (12) :1697-1701
[4]
Risk factors for surgery and postoperative recurrence in Crohn's disease [J].
Bernell, O ;
Lapidus, A ;
Hellers, G .
ANNALS OF SURGERY, 2000, 231 (01) :38-45
[5]
Inflammatory bowel disease and smoking -: A review of epidemiology, pathophysiology, and therapeutic implications [J].
Birrenbach, T ;
Böcker, U .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) :848-859
[6]
Preventing postoperative recurrence of Crohn's disease [J].
Borley, NR ;
Mortensen, NJ ;
Jewell, DP .
BRITISH JOURNAL OF SURGERY, 1997, 84 (11) :1493-1502
[7]
Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables [J].
Camma, C ;
Giunta, M ;
Rosselli, M ;
Cottone, M .
GASTROENTEROLOGY, 1997, 113 (05) :1465-1473
[8]
CAPRILLI R, 1994, ALIMENT PHARM THER, V8, P35
[9]
The quality of life in patients with Crohn's disease [J].
Cohen, RD .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (09) :1603-1609
[10]
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery [J].
Cosnes, J ;
Nion-Larmurier, I ;
Beaugerie, L ;
Afchain, P ;
Tiret, E ;
Gendre, JP .
GUT, 2005, 54 (02) :237-241